Philadelphia Clinical Research Learning Institute
An intensive program dedicated to educating attendees on clinical research and therapy development and empowering this group to be advocates for ALS clinical research. Learn more about attending>>
Cytokinetics Announces Opening of BENEFIT-ALS A Phase IIb Clinical Trial of Tirasemtiv (CK-2017357)
As sites become activated for this Phase IIB BENEFIT-ALS trial, they will be added to the NEALS trial database.
Find research sites>>